As of 12:30 PM on the 3rd, Celltrion is trading at 342,000 KRW, down 3.8% from the previous day. This represents a 10.94% decline compared to January 12. Celltrion is known as a protein and biopharmaceutical manufacturing company.

Today, foreigners have net sold 137,180 shares of Celltrion, and institutions have net sold 2,000 shares, according to provisional data. Over the past five days, individual investors have net sold 1,721,213 shares, while foreigners and institutions have net bought 1,588,816 shares and 223,720 shares, respectively.


On February 1, Celltrion became a market issue with the headline "Remsima SC Approval and Anti-Short Selling Related Stock... Stock Price Surges 14%."





[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an article automation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing